DHL Group has acquired 100% of CRYOPDP, a specialty courier focused on clinical trials, biopharma, and cell and gene ...

Sartorius has earned certificates from the International Sustainability and Carbon Certification for its production sites in ...

ProBioGen has appointed Dr. Alfred Merz, PhD, as Chief Executive Officer (CEO), effective April 1, 2025. Dr. Merz previously ...

Novo Nordisk has entered into an exclusive license agreement with Lexicon Pharmaceuticals Inc. for LX9851, a first-in-class, ...

Curium Pharma, a developer, manufacturer, and distributor of nuclear medicine, has acquired Eczacıbaşı-Monrol Nuclear ...

Merck has shared data from the pivotal Phase 3 trial evaluating the subcutaneous administration of pembrolizumab together ...

How innovation, advanced manufacturing, and expertise drive success in the evolving CDMO and generics landscape.

BSI’s goal is to make QS-21 accessible to a wider range of vaccines and populations, particularly in low-income countries.

National Resilience Inc., a technology-focused biomanufacturing company, is initiating the next phase of its growth in the ...

Linearis has inaugurated a new laboratory in the greater Quebec City region and introduced its high-throughput metabolomics ...